Table 2.
Area of expression of insulin-like growth factor (IGF)-I in the lesions of cutaneous leishmaniasis patients according to the duration of illness and response to treatment.
| Groups | IGF-I-area % | P | ||
|---|---|---|---|---|
| Median | Mean ± SD | |||
| Duration of illness | Early lesion (n = 7) | 1.47 | 1.52 ± 1.12 |
∗∗
r = 0.42 0.023 |
| Intermediate (n = 10) | 1.50 | 2.32 ± 2.47 | ||
| Late lesion (n = 8) | 3.12 | 3.18 ± 1.90 | ||
|
| ||||
| Treatment response | Good responder (n = 18) | 2.10 | 2.80 ± 2.10 | #0.03 |
| Poor response (n = 6) | 1.05 | 1.30 ± 1.10 | ||
∗∗Spearman correlation, #Mann-Whitney test.